Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Raw Materials (2016 - 2018)

Historic Raw Materials for Varex Imaging (VREX) over the last 3 years, with Q2 2018 value amounting to $150.7 million.

  • Varex Imaging's Raw Materials fell 2064.24% to $150.7 million in Q2 2018 from the same period last year, while for Jun 2018 it was $150.7 million, marking a year-over-year decrease of 2064.24%. This contributed to the annual value of $164.5 million for FY2017, which is 966.67% up from last year.
  • Varex Imaging's Raw Materials amounted to $150.7 million in Q2 2018, which was down 2064.24% from $148.7 million recorded in Q1 2018.
  • Over the past 5 years, Varex Imaging's Raw Materials peaked at $189.9 million during Q2 2017, and registered a low of $148.7 million during Q1 2018.
  • Its 3-year average for Raw Materials is $162.5 million, with a median of $163.0 million in 2016.
  • As far as peak fluctuations go, Varex Imaging's Raw Materials skyrocketed by 966.67% in 2017, and later plummeted by 2064.24% in 2018.
  • Varex Imaging's Raw Materials (Quarter) stood at $161.6 million in 2016, then increased by 4.95% to $169.6 million in 2017, then fell by 11.14% to $150.7 million in 2018.
  • Its Raw Materials was $150.7 million in Q2 2018, compared to $148.7 million in Q1 2018 and $169.6 million in Q4 2017.